# Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antitumor-activity-of-pembrolizumab-in-biomarker-unselected-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Laura Q.M. Chow,Robert I. Haddad,Shilpa Gupta,Amit Mahipal,Ranee Mehra,Makoto Tahara,Raanan Berger,Joseph P. Eder,Barbara Burtness,Se‐Hoon Lee,Bhumsuk Keam,Hyunseok Kang,Kei Muro,Jared Weiss,Ravit Geva,Chia‐Chi Lin,Hyun Cheol Chung,Amy Meister,Marisa Dolled‐Filhart,Kumudu Pathiraja,Jonathan D. Cheng,Tanguy Y. Seiwert |
| Citations | 863 |
| DOI | 10.1200/jco.2016.68.1478 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/6804896 |
| OpenAlex ID | https://openalex.org/W2523194272 |
| PMID | 27646946 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Se‐Hoon Lee](https://scholariq.org/researchers/se-hoon-lee/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.